{"entity":{"type":"insider","cik":"0001272354","url":"/insider/0001272354","json_url":"/insider/0001272354.json","name":"COHEN RON","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":631,"n_filings":51,"first":"2006-10-18","last":"2023-03-20","span_basis":"filed_date"},"name_variants":[{"name":"COHEN RON","source":"filing","n_filings":51,"first_seen":"2006-10-18","last_seen":"2023-03-20"}],"transactions":[{"id":8437634,"accession":"0001209191-23-020044","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-020044","line_url":"/filing/0001209191-23-020044#line-2","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"Acorda Therapeutics, Inc.","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272354","owner_name":"COHEN RON","owner_display_name":"COHEN RON","owner_url":"/insider/0001272354","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.65,"price_display":"0.65","price_state":"stated","total_value":6500.0,"total_display":"6,500.00","total_whole":"6,500","shares_owned_after":149757.0,"shares_owned_after_display":"149,757","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-17","filed_date":"2023-03-20","scope":"insider"},{"id":8437629,"accession":"0001209191-23-020044","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-020044","line_url":"/filing/0001209191-23-020044#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"Acorda Therapeutics, Inc.","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272354","owner_name":"COHEN RON","owner_display_name":"COHEN RON","owner_url":"/insider/0001272354","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10156.0,"shares_display":"10,156","price_per_share":0.6,"price_display":"0.60","price_state":"stated","total_value":6093.6,"total_display":"6,093.60","total_whole":"6,094","shares_owned_after":139757.0,"shares_owned_after_display":"139,757","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-16","filed_date":"2023-03-20","scope":"insider"},{"id":6890891,"accession":"0001209191-22-020260","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-020260","line_url":"/filing/0001209191-22-020260#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272354","owner_name":"COHEN RON","owner_display_name":"COHEN RON","owner_url":"/insider/0001272354","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2289.0,"shares_display":"2,289","price_per_share":1.7014,"price_display":"1.70","price_state":"stated","total_value":3894.5046,"total_display":"3,894.50","total_whole":"3,895","shares_owned_after":129601.0,"shares_owned_after_display":"129,601","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-17","filed_date":"2022-03-21","scope":"insider"},{"id":8321387,"accession":"0001209191-19-058936","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-058936","line_url":"/filing/0001209191-19-058936#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272354","owner_name":"COHEN RON","owner_display_name":"COHEN RON","owner_url":"/insider/0001272354","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4699.0,"shares_display":"4,699","price_per_share":1.5972,"price_display":"1.60","price_state":"stated","total_value":7505.2428,"total_display":"7,505.24","total_whole":"7,505","shares_owned_after":607287.0,"shares_owned_after_display":"607,287","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-02","filed_date":"2019-12-04","scope":"insider"},{"id":6106057,"accession":"0001209191-18-061102","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-061102","line_url":"/filing/0001209191-18-061102#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272354","owner_name":"COHEN RON","owner_display_name":"COHEN RON","owner_url":"/insider/0001272354","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3620.0,"shares_display":"3,620","price_per_share":20.5951,"price_display":"20.60","price_state":"stated","total_value":74554.262,"total_display":"74,554.26","total_whole":"74,554","shares_owned_after":487554.0,"shares_owned_after_display":"487,554","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-03","filed_date":"2018-12-06","scope":"insider"},{"id":4267082,"accession":"0001209191-17-041047","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-041047","line_url":"/filing/0001209191-17-041047#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272354","owner_name":"COHEN RON","owner_display_name":"COHEN RON","owner_url":"/insider/0001272354","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":16.9499,"price_display":"16.95","price_state":"stated","total_value":338998.0,"total_display":"338,998.00","total_whole":"338,998","shares_owned_after":511648.0,"shares_owned_after_display":"511,648","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-16","filed_date":"2017-06-20","scope":"insider"},{"id":3298909,"accession":"0001209191-16-155530","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-16-155530","line_url":"/filing/0001209191-16-155530","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272354","owner_name":"COHEN RON","owner_display_name":"COHEN RON","owner_url":"/insider/0001272354","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40172.0,"shares_display":"40,172","price_per_share":20.752134421985463,"price_display":"20.75","price_state":"stated","total_value":833654.744,"total_display":"833,654.74","total_whole":"833,655","shares_owned_after":480096.0,"shares_owned_after_display":"480,096","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-14","filed_date":"2016-12-16","scope":"insider","n_lines":2},{"id":2422695,"accession":"0001209191-16-153401","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-153401","line_url":"/filing/0001209191-16-153401#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272354","owner_name":"COHEN RON","owner_display_name":"COHEN RON","owner_url":"/insider/0001272354","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7160.0,"shares_display":"7,160","price_per_share":20.7377,"price_display":"20.74","price_state":"stated","total_value":148481.932,"total_display":"148,481.93","total_whole":"148,482","shares_owned_after":479688.0,"shares_owned_after_display":"479,688","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-01","filed_date":"2016-12-05","scope":"insider"},{"id":8084977,"accession":"0001209191-15-083223","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-083223","line_url":"/filing/0001209191-15-083223#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272354","owner_name":"COHEN RON","owner_display_name":"COHEN RON","owner_url":"/insider/0001272354","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11850.0,"shares_display":"11,850","price_per_share":38.0781,"price_display":"38.08","price_state":"stated","total_value":451225.485,"total_display":"451,225.48","total_whole":"451,225","shares_owned_after":400550.0,"shares_owned_after_display":"400,550","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-01","filed_date":"2015-12-03","scope":"insider"},{"id":8849068,"accession":"0001209191-15-074442","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-15-074442","line_url":"/filing/0001209191-15-074442#line-7","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272354","owner_name":"COHEN RON","owner_display_name":"COHEN RON","owner_url":"/insider/0001272354","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":910.0,"shares_display":"910","price_per_share":30.1,"price_display":"30.10","price_state":"stated","total_value":27391.0,"total_display":"27,391.00","total_whole":"27,391","shares_owned_after":412400.0,"shares_owned_after_display":"412,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-10-05","filed_date":"2015-10-06","scope":"insider"},{"id":8849064,"accession":"0001209191-15-074442","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-15-074442","line_url":"/filing/0001209191-15-074442#line-5","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272354","owner_name":"COHEN RON","owner_display_name":"COHEN RON","owner_url":"/insider/0001272354","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":134090.0,"shares_display":"134,090","price_per_share":28.0121,"price_display":"28.01","price_state":"stated","total_value":3756142.489,"total_display":"3,756,142.49","total_whole":"3,756,142","shares_owned_after":412400.0,"shares_owned_after_display":"412,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-10-02","filed_date":"2015-10-06","scope":"insider"},{"id":6742565,"accession":"0001209191-14-072924","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-072924","line_url":"/filing/0001209191-14-072924#line-2","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272354","owner_name":"COHEN RON","owner_display_name":"COHEN RON","owner_url":"/insider/0001272354","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34394.0,"shares_display":"34,394","price_per_share":35.5918,"price_display":"35.59","price_state":"stated","total_value":1224144.3692,"total_display":"1,224,144.37","total_whole":"1,224,144","shares_owned_after":495400.0,"shares_owned_after_display":"495,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-01","filed_date":"2014-12-03","scope":"insider"},{"id":4568561,"accession":"0001209191-13-055274","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-055274","line_url":"/filing/0001209191-13-055274#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272354","owner_name":"COHEN RON","owner_display_name":"COHEN RON","owner_url":"/insider/0001272354","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18125.0,"shares_display":"18,125","price_per_share":33.5155,"price_display":"33.52","price_state":"stated","total_value":607468.4375,"total_display":"607,468.44","total_whole":"607,468","shares_owned_after":460743.0,"shares_owned_after_display":"460,743","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-02","filed_date":"2013-12-04","scope":"insider"},{"id":5562238,"accession":"0001209191-13-041574","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001209191-13-041574","line_url":"/filing/0001209191-13-041574","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272354","owner_name":"COHEN RON","owner_display_name":"COHEN RON","owner_url":"/insider/0001272354","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31945.0,"shares_display":"31,945","price_per_share":34.35420410079825,"price_display":"34.35","price_state":"stated","total_value":1097445.05,"total_display":"1,097,445.05","total_whole":"1,097,445","shares_owned_after":343930.0,"shares_owned_after_display":"343,930","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-20","filed_date":"2013-08-20","scope":"insider","n_lines":2},{"id":5562228,"accession":"0001209191-13-041574","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-13-041574","line_url":"/filing/0001209191-13-041574#line-5","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272354","owner_name":"COHEN RON","owner_display_name":"COHEN RON","owner_url":"/insider/0001272354","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":55993.0,"shares_display":"55,993","price_per_share":34.02,"price_display":"34.02","price_state":"stated","total_value":1904881.86,"total_display":"1,904,881.86","total_whole":"1,904,882","shares_owned_after":338090.0,"shares_owned_after_display":"338,090","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-19","filed_date":"2013-08-20","scope":"insider"},{"id":5562224,"accession":"0001209191-13-041574","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-13-041574","line_url":"/filing/0001209191-13-041574#line-3","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272354","owner_name":"COHEN RON","owner_display_name":"COHEN RON","owner_url":"/insider/0001272354","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":61062.0,"shares_display":"61,062","price_per_share":34.04,"price_display":"34.04","price_state":"stated","total_value":2078550.48,"total_display":"2,078,550.48","total_whole":"2,078,550","shares_owned_after":338090.0,"shares_owned_after_display":"338,090","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-16","filed_date":"2013-08-20","scope":"insider"},{"id":4846139,"accession":"0001209191-13-031830","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-031830","line_url":"/filing/0001209191-13-031830#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272354","owner_name":"COHEN RON","owner_display_name":"COHEN RON","owner_url":"/insider/0001272354","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11000.0,"shares_display":"11,000","price_per_share":34.15,"price_display":"34.15","price_state":"stated","total_value":375650.0,"total_display":"375,650.00","total_whole":"375,650","shares_owned_after":338090.0,"shares_owned_after_display":"338,090","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-10","filed_date":"2013-06-12","scope":"insider"},{"id":3297849,"accession":"0001209191-12-055897","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-055897","line_url":"/filing/0001209191-12-055897#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272354","owner_name":"COHEN RON","owner_display_name":"COHEN RON","owner_url":"/insider/0001272354","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16407.0,"shares_display":"16,407","price_per_share":24.2223,"price_display":"24.22","price_state":"stated","total_value":397415.2761,"total_display":"397,415.28","total_whole":"397,415","shares_owned_after":326590.0,"shares_owned_after_display":"326,590","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-12-03","filed_date":"2012-12-05","scope":"insider"},{"id":9075527,"accession":"0001209191-11-059454","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-059454","line_url":"/filing/0001209191-11-059454#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272354","owner_name":"COHEN RON","owner_display_name":"COHEN RON","owner_url":"/insider/0001272354","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16500.0,"shares_display":"16,500","price_per_share":22.92,"price_display":"22.92","price_state":"stated","total_value":378180.0,"total_display":"378,180.00","total_whole":"378,180","shares_owned_after":305497.0,"shares_owned_after_display":"305,497","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-12-01","filed_date":"2011-12-05","scope":"insider"},{"id":9096143,"accession":"0001209191-11-033884","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-033884","line_url":"/filing/0001209191-11-033884#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272354","owner_name":"COHEN RON","owner_display_name":"COHEN RON","owner_url":"/insider/0001272354","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":30.87,"price_display":"30.87","price_state":"stated","total_value":370440.0,"total_display":"370,440.00","total_whole":"370,440","shares_owned_after":321997.0,"shares_owned_after_display":"321,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-06-08","filed_date":"2011-06-09","scope":"insider"},{"id":9103515,"accession":"0001209191-11-031856","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-11-031856","line_url":"/filing/0001209191-11-031856#line-2","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272354","owner_name":"COHEN RON","owner_display_name":"COHEN RON","owner_url":"/insider/0001272354","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":32.58,"price_display":"32.58","price_state":"stated","total_value":1954800.0,"total_display":"1,954,800.00","total_whole":"1,954,800","shares_owned_after":333997.0,"shares_owned_after_display":"333,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-26","filed_date":"2011-05-31","scope":"insider"},{"id":8833092,"accession":"0001209191-11-023348","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-11-023348","line_url":"/filing/0001209191-11-023348#line-2","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272354","owner_name":"COHEN RON","owner_display_name":"COHEN RON","owner_url":"/insider/0001272354","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":28.24,"price_display":"28.24","price_state":"stated","total_value":1694400.0,"total_display":"1,694,400.00","total_whole":"1,694,400","shares_owned_after":333997.0,"shares_owned_after_display":"333,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-04-18","filed_date":"2011-04-19","scope":"insider"},{"id":7741665,"accession":"0001209191-10-058324","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-10-058324","line_url":"/filing/0001209191-10-058324","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272354","owner_name":"COHEN RON","owner_display_name":"COHEN RON","owner_url":"/insider/0001272354","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":26.533933333333334,"price_display":"26.53","price_state":"stated","total_value":398009.0,"total_display":"398,009.00","total_whole":"398,009","shares_owned_after":290247.0,"shares_owned_after_display":"290,247","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-12-01","filed_date":"2010-12-03","scope":"insider","n_lines":2},{"id":7671054,"accession":"0001209191-10-041720","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-10-041720","line_url":"/filing/0001209191-10-041720","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272354","owner_name":"COHEN RON","owner_display_name":"COHEN RON","owner_url":"/insider/0001272354","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":55000.0,"shares_display":"55,000","price_per_share":35.931396,"price_display":"35.93","price_state":"stated","total_value":1976226.78,"total_display":"1,976,226.78","total_whole":"1,976,227","shares_owned_after":293334.0,"shares_owned_after_display":"293,334","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-08-05","filed_date":"2010-08-09","scope":"insider","n_lines":2},{"id":7205795,"accession":"0001209191-10-015960","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-10-015960","line_url":"/filing/0001209191-10-015960#line-4","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272354","owner_name":"COHEN RON","owner_display_name":"COHEN RON","owner_url":"/insider/0001272354","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19000.0,"shares_display":"19,000","price_per_share":33.7253,"price_display":"33.73","price_state":"stated","total_value":640780.7,"total_display":"640,780.70","total_whole":"640,781","shares_owned_after":169884.0,"shares_owned_after_display":"169,884","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-03-09","filed_date":"2010-03-10","scope":"insider"},{"id":7205791,"accession":"0001209191-10-015960","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-10-015960","line_url":"/filing/0001209191-10-015960#line-2","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272354","owner_name":"COHEN RON","owner_display_name":"COHEN RON","owner_url":"/insider/0001272354","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19000.0,"shares_display":"19,000","price_per_share":33.1502,"price_display":"33.15","price_state":"stated","total_value":629853.8,"total_display":"629,853.80","total_whole":"629,854","shares_owned_after":169884.0,"shares_owned_after_display":"169,884","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-03-08","filed_date":"2010-03-10","scope":"insider"},{"id":5720363,"accession":"0001209191-09-055189","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-055189","line_url":"/filing/0001209191-09-055189#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272354","owner_name":"COHEN RON","owner_display_name":"COHEN RON","owner_url":"/insider/0001272354","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8500.0,"shares_display":"8,500","price_per_share":24.5052,"price_display":"24.51","price_state":"stated","total_value":208294.2,"total_display":"208,294.20","total_whole":"208,294","shares_owned_after":169884.0,"shares_owned_after_display":"169,884","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-01","filed_date":"2009-12-03","scope":"insider"},{"id":2636369,"accession":"0001209191-08-063862","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-08-063862","line_url":"/filing/0001209191-08-063862#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272354","owner_name":"COHEN RON","owner_display_name":"COHEN RON","owner_url":"/insider/0001272354","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":15.89,"price_display":"15.89","price_state":"stated","total_value":63560.0,"total_display":"63,560.00","total_whole":"63,560","shares_owned_after":153384.0,"shares_owned_after_display":"153,384","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-12-01","filed_date":"2008-12-03","scope":"insider"},{"id":3841374,"accession":"0001179110-08-016584","txn_seq":29,"anchor":"line-29","filing_url":"/filing/0001179110-08-016584","line_url":"/filing/0001179110-08-016584#line-29","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272354","owner_name":"COHEN RON","owner_display_name":"COHEN RON","owner_url":"/insider/0001272354","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1700.0,"shares_display":"1,700","price_per_share":29.74,"price_display":"29.74","price_state":"stated","total_value":50558.0,"total_display":"50,558.00","total_whole":"50,558","shares_owned_after":173064.0,"shares_owned_after_display":"173,064","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-08","filed_date":"2008-09-10","scope":"insider"},{"id":3841373,"accession":"0001179110-08-016584","txn_seq":28,"anchor":"line-28","filing_url":"/filing/0001179110-08-016584","line_url":"/filing/0001179110-08-016584#line-28","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272354","owner_name":"COHEN RON","owner_display_name":"COHEN RON","owner_url":"/insider/0001272354","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1100.0,"shares_display":"1,100","price_per_share":29.76,"price_display":"29.76","price_state":"stated","total_value":32736.0,"total_display":"32,736.00","total_whole":"32,736","shares_owned_after":175533.0,"shares_owned_after_display":"175,533","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-08","filed_date":"2008-09-10","scope":"insider"},{"id":3841372,"accession":"0001179110-08-016584","txn_seq":27,"anchor":"line-27","filing_url":"/filing/0001179110-08-016584","line_url":"/filing/0001179110-08-016584#line-27","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272354","owner_name":"COHEN RON","owner_display_name":"COHEN RON","owner_url":"/insider/0001272354","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1099.0,"shares_display":"1,099","price_per_share":29.72,"price_display":"29.72","price_state":"stated","total_value":32662.28,"total_display":"32,662.28","total_whole":"32,662","shares_owned_after":171165.0,"shares_owned_after_display":"171,165","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-08","filed_date":"2008-09-10","scope":"insider"},{"id":3841368,"accession":"0001179110-08-016584","txn_seq":26,"anchor":"line-26","filing_url":"/filing/0001179110-08-016584","line_url":"/filing/0001179110-08-016584#line-26","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272354","owner_name":"COHEN RON","owner_display_name":"COHEN RON","owner_url":"/insider/0001272354","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":29.7,"price_display":"29.70","price_state":"stated","total_value":29700.0,"total_display":"29,700.00","total_whole":"29,700","shares_owned_after":169364.0,"shares_owned_after_display":"169,364","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-08","filed_date":"2008-09-10","scope":"insider"},{"id":3841364,"accession":"0001179110-08-016584","txn_seq":25,"anchor":"line-25","filing_url":"/filing/0001179110-08-016584","line_url":"/filing/0001179110-08-016584#line-25","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272354","owner_name":"COHEN RON","owner_display_name":"COHEN RON","owner_url":"/insider/0001272354","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":29.79,"price_display":"29.79","price_state":"stated","total_value":26811.0,"total_display":"26,811.00","total_whole":"26,811","shares_owned_after":177433.0,"shares_owned_after_display":"177,433","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-08","filed_date":"2008-09-10","scope":"insider"},{"id":3841362,"accession":"0001179110-08-016584","txn_seq":24,"anchor":"line-24","filing_url":"/filing/0001179110-08-016584","line_url":"/filing/0001179110-08-016584#line-24","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272354","owner_name":"COHEN RON","owner_display_name":"COHEN RON","owner_url":"/insider/0001272354","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":801.0,"shares_display":"801","price_per_share":29.71,"price_display":"29.71","price_state":"stated","total_value":23797.71,"total_display":"23,797.71","total_whole":"23,798","shares_owned_after":170364.0,"shares_owned_after_display":"170,364","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-08","filed_date":"2008-09-10","scope":"insider"},{"id":3841361,"accession":"0001179110-08-016584","txn_seq":23,"anchor":"line-23","filing_url":"/filing/0001179110-08-016584","line_url":"/filing/0001179110-08-016584#line-23","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272354","owner_name":"COHEN RON","owner_display_name":"COHEN RON","owner_url":"/insider/0001272354","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":29.73,"price_display":"29.73","price_state":"stated","total_value":23784.0,"total_display":"23,784.00","total_whole":"23,784","shares_owned_after":172264.0,"shares_owned_after_display":"172,264","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-08","filed_date":"2008-09-10","scope":"insider"},{"id":3841359,"accession":"0001179110-08-016584","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001179110-08-016584","line_url":"/filing/0001179110-08-016584#line-22","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272354","owner_name":"COHEN RON","owner_display_name":"COHEN RON","owner_url":"/insider/0001272354","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":769.0,"shares_display":"769","price_per_share":29.75,"price_display":"29.75","price_state":"stated","total_value":22877.75,"total_display":"22,877.75","total_whole":"22,878","shares_owned_after":174764.0,"shares_owned_after_display":"174,764","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-08","filed_date":"2008-09-10","scope":"insider"},{"id":3841357,"accession":"0001179110-08-016584","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001179110-08-016584","line_url":"/filing/0001179110-08-016584#line-21","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272354","owner_name":"COHEN RON","owner_display_name":"COHEN RON","owner_url":"/insider/0001272354","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":29.81,"price_display":"29.81","price_state":"stated","total_value":20867.0,"total_display":"20,867.00","total_whole":"20,867","shares_owned_after":178784.0,"shares_owned_after_display":"178,784","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-08","filed_date":"2008-09-10","scope":"insider"},{"id":3841354,"accession":"0001179110-08-016584","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001179110-08-016584","line_url":"/filing/0001179110-08-016584#line-20","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272354","owner_name":"COHEN RON","owner_display_name":"COHEN RON","owner_url":"/insider/0001272354","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":451.0,"shares_display":"451","price_per_share":29.8,"price_display":"29.80","price_state":"stated","total_value":13439.8,"total_display":"13,439.80","total_whole":"13,440","shares_owned_after":178333.0,"shares_owned_after_display":"178,333","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-08","filed_date":"2008-09-10","scope":"insider"},{"id":3841353,"accession":"0001179110-08-016584","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001179110-08-016584","line_url":"/filing/0001179110-08-016584#line-19","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272354","owner_name":"COHEN RON","owner_display_name":"COHEN RON","owner_url":"/insider/0001272354","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":433.0,"shares_display":"433","price_per_share":29.78,"price_display":"29.78","price_state":"stated","total_value":12894.74,"total_display":"12,894.74","total_whole":"12,895","shares_owned_after":177000.0,"shares_owned_after_display":"177,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-08","filed_date":"2008-09-10","scope":"insider"},{"id":3841350,"accession":"0001179110-08-016584","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001179110-08-016584","line_url":"/filing/0001179110-08-016584#line-18","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272354","owner_name":"COHEN RON","owner_display_name":"COHEN RON","owner_url":"/insider/0001272354","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":30.17,"price_display":"30.17","price_state":"stated","total_value":12068.0,"total_display":"12,068.00","total_whole":"12,068","shares_owned_after":181484.0,"shares_owned_after_display":"181,484","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-08","filed_date":"2008-09-10","scope":"insider"},{"id":3841346,"accession":"0001179110-08-016584","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001179110-08-016584","line_url":"/filing/0001179110-08-016584#line-17","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272354","owner_name":"COHEN RON","owner_display_name":"COHEN RON","owner_url":"/insider/0001272354","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":367.0,"shares_display":"367","price_per_share":29.77,"price_display":"29.77","price_state":"stated","total_value":10925.59,"total_display":"10,925.59","total_whole":"10,926","shares_owned_after":176633.0,"shares_owned_after_display":"176,633","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-08","filed_date":"2008-09-10","scope":"insider"},{"id":3841343,"accession":"0001179110-08-016584","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001179110-08-016584","line_url":"/filing/0001179110-08-016584#line-16","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272354","owner_name":"COHEN RON","owner_display_name":"COHEN RON","owner_url":"/insider/0001272354","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":29.89,"price_display":"29.89","price_state":"stated","total_value":8967.0,"total_display":"8,967.00","total_whole":"8,967","shares_owned_after":180784.0,"shares_owned_after_display":"180,784","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-08","filed_date":"2008-09-10","scope":"insider"},{"id":3841341,"accession":"0001179110-08-016584","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001179110-08-016584","line_url":"/filing/0001179110-08-016584#line-15","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272354","owner_name":"COHEN RON","owner_display_name":"COHEN RON","owner_url":"/insider/0001272354","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":29.87,"price_display":"29.87","price_state":"stated","total_value":8961.0,"total_display":"8,961.00","total_whole":"8,961","shares_owned_after":180384.0,"shares_owned_after_display":"180,384","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-08","filed_date":"2008-09-10","scope":"insider"},{"id":3841339,"accession":"0001179110-08-016584","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001179110-08-016584","line_url":"/filing/0001179110-08-016584#line-14","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272354","owner_name":"COHEN RON","owner_display_name":"COHEN RON","owner_url":"/insider/0001272354","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":29.82,"price_display":"29.82","price_state":"stated","total_value":8946.0,"total_display":"8,946.00","total_whole":"8,946","shares_owned_after":179484.0,"shares_owned_after_display":"179,484","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-08","filed_date":"2008-09-10","scope":"insider"},{"id":3841337,"accession":"0001179110-08-016584","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001179110-08-016584","line_url":"/filing/0001179110-08-016584#line-13","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272354","owner_name":"COHEN RON","owner_display_name":"COHEN RON","owner_url":"/insider/0001272354","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":30.32,"price_display":"30.32","price_state":"stated","total_value":6064.0,"total_display":"6,064.00","total_whole":"6,064","shares_owned_after":181884.0,"shares_owned_after_display":"181,884","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-08","filed_date":"2008-09-10","scope":"insider"},{"id":3841335,"accession":"0001179110-08-016584","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001179110-08-016584","line_url":"/filing/0001179110-08-016584#line-12","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001272354","owner_name":"COHEN RON","owner_display_name":"COHEN RON","owner_url":"/insider/0001272354","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":29.97,"price_display":"29.97","price_state":"stated","total_value":5994.0,"total_display":"5,994.00","total_whole":"5,994","shares_owned_after":181084.0,"shares_owned_after_display":"181,084","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-08","filed_date":"2008-09-10","scope":"insider"}],"collapsed":true,"next_cursor":"2008-09-08|3841335","ledger_fault":false,"count":{"value":631,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":628,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":631},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001008848","name":"Acorda Therapeutics, Inc.","url":"/issuer/0001008848","role":"Director, Officer (President and CEO)","n_filings":51,"first_seen":"2006-10-18","last_seen":"2023-03-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001272354","retrieved_at":"2026-08-24T21:42:29+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}